[18F]fluorodeoxyglucose positron emission tomography for detection of bone marrow involvement in children and adolescents with Hodgkin's lymphoma

Journal of Clinical Oncology

Volumn 29, Issue 26, 2011, Pages 3523-3528

  Purz, Sandra ^a   Mauz Körholz, Christine ^b   Körholz, Dieter ^b   Hasenclever, Dirk ^a   Krausse, Antje ^a   Sorge, Ina ^a   Ruschke, Kathrin ^b   Stiefel, Martina ^b   Amthauer, Holger ^c   Schober, Otmar ^d   Kranert, W Tilman ^e   Weber, Wolfgang A ^f   Haberkorn, Uwe ^h   Hundsdor̈fer, Patrick ^c   Ehlert, Karoline ^d   Becker, Martina ^e   Ros̈sler, Jochen ^g   Kulozik, Andreas E ⁱ   Sabri, Osama ^a   Kluge, Regine ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e GOETHE UNIVERSITY   (Germany)

^f UNIVERSITY OF FREIBURG   (Germany)

^g UNIVERSITY OF FREIBURG   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE F 18; PREDNISOLONE; VINBLASTINE; VINCRISTINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADOLESCENT; ARTICLE; BONE MARROW BIOPSY; BONE MARROW METASTASIS; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER SCREENING; CANCER STAGING; CANCER SURVIVAL; CHILDHOOD CANCER; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; BIOPSY; BONE MARROW CANCER; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; METASTASIS; MULTICENTER STUDY; PATHOLOGY; SCINTISCANNING;

ADOLESCENT; BIOPSY; BONE MARROW NEOPLASMS; CHILD; FEMALE; FLUORODEOXYGLUCOSE F18; HODGKIN DISEASE; HUMANS; MALE; NEOPLASM STAGING; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 80053002702     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.32.4996     Document Type: Article

References (27)

1. Hennekeuser HH, Möbius W, Obrecht P, et al: Bone marrow biopsy in malignant lymphomas [in German]. Klin Wochenschr 52:118-122, 1974
2. Munker R, Hasenclever D, Brosteanu O, et al: Bone marrow involvement in Hodgkin's disease: An analysis of 135 consecutive cases. German Hodgkin's Lymphoma Study Group. J Clin Oncol 13:403-409, 1995
3. Vassilakopoulos TP, Angelopoulou MK, Constantinou N, et al: Development and validation of a clinical prediction rule for bone marrow involvement in patients with Hodgkin lymphoma. Blood 105:1875-1880, 2005 (Pubitemid 40731767)
4. O'Carroll DI, McKenna RW, Brunning RD: Bone marrow manifestations of Hodgkin's disease. Cancer 38:1717-1728, 1976
5. Schaefer NG, Strobel K, Taverna C, et al: Bone involvement in patients with lymphoma: The role of FDG-PET/CT. Eur J Nucl Med Mol Imaging 34:60-67, 2007 (Pubitemid 44885555)
6. Moog F, Bangerter M, Kotzerke J, et al: 18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow. J Clin Oncol 16:603-609, 1998 (Pubitemid 28135606)
7. Mauz-Körholz C, Hasenclever D, Dörffel W, et al: Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: The GPOH-HD-2002 Study. J Clin Oncol 10:3680-3686, 2010
8. Stauss J, Franzius C, Pfluger T, et al: Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology. Eur J Nucl Med Mol Imaging 35:1581-1588, 2008
9. Lassmann M, Biassoni L, Monsieurs M, et al: The new EANM paediatric dosage card: Additional notes with respect to F-18. Eur J Nucl Med Mol Imaging 35:1666-1668, 2008
10. Hahn K, Fischer S, Colarinha P, et al: Guidelines for bone scintigraphy in children. Eur J Nucl Med 28:42-47, 2001
11. Pelosi E, Penna D, Deandreis D, et al: FDG-PET in the detection of bone marrow disease in Hodgkin's disease and aggressive non-Hodgkin's lymphoma and its impact on clinical management. Quart J Nucl Med Mol Img 52:9-16, 2008 (Pubitemid 351351040)
12. Cerci JJ, Praccia LF, Soares J, et al: Positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose for initial staging of Hodgkin lymphoma: A single center experience in Brazil. Clinics (Sao Paulo) 64:491-498, 2009
13. Simpson CD, Gao J, Fernandez CV, et al: Routine bone marrow examination in the initial evaluation of paediatric Hodgkin lymphoma: The Canadian perspective. Br J Haematol 141:820-826, 2008 (Pubitemid 351724852)
14. Mahoney DH Jr, Schreuders LC, Gresik MV, et al: Role of staging bone marrow examination in children with Hodgkin disease. Med Pediatr Oncol 30:175-177, 1998 (Pubitemid 28028524)
15. Shulkin BL, Goodin GS, McCarville MB, et al: Bone and [18F]fluorodeoxyglucose positron-emission tomography/computed tomography scanning for the assessment of osseous involvement in Hodgkin lymphoma in children and young adults. Leuk Lymphoma 50:1794-1802, 2009
16. Horan FT: Bone involvement in Hodgkin's disease. A survey of 201 cases. Br J Surg 56:277-281, 1969
17. Feltl D, Markova J, Mocikova H, et al: Prognostic impact of bone involvement in Hodgkin lymphoma. Neoplasma 55:96-100, 2008
18. Carr R, Barrington SF, Madan B, et al: Detection of lymphoma in bone marrow by whole-body positron emission tomography. Blood 91:3340-3346, 1998 (Pubitemid 28193885)
19. Rosenberg SA: Hodgkin's disease of the bone marrow. Cancer Res 31:1733-1736, 1971
20. Menon NC, Buchanan JG: Bilateral trephine bone marrow biopsies in Hodgkin's and non-Hodgkin's lymphoma. Pathology 11:53-57, 1979 (Pubitemid 9133913)
21. Doll DC, Ringenberg QS, Anderson SP, et al: Bone marrow biopsy in the initial staging of Hodgkin's disease. Med Pediatr Oncol 17:1-5, 1989 (Pubitemid 19051063)
22. Bartl R, Frisch B, Burkhardt R, et al: Assessment of bone marrow histology in Hodgkin's disease: Correlation with clinical factors. Br J Haematol 51:345-360, 1982 (Pubitemid 12045308)
23. Ellis ME, Diehl LF, Granger E, et al: Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: Sensitivity and specificity of the Ann Arbor staging procedure criteria. Am J Hematol 30:115-120, 1989 (Pubitemid 19059811)
24. Howell SJ, Grey M, Chang J, et al: The value of bone marrow examination in the staging of Hodgkin's lymphoma: A review of 955 cases seen in a regional cancer centre. Br J Haematol 119:408-411, 2002 (Pubitemid 35365491)
25. Buchmann I, Reinhardt M, Elsner K, et al: 2-(fluorine-18)fluoro-2-deoxy- D-glucose positron emission tomography in the detection and staging of malignant lymphoma. A bicenter trial. Cancer 91:889-899, 2001
26. Fuster D, Chiang S, Andreadis C, et al: Can [18F]fluorodeoxyglucose positron emission tomography imaging complement biopsy results from the iliac crest for the detection of bone marrow involvement in patients with malignant lymphoma? Nucl Med Commun 27:11-15, 2006 (Pubitemid 44391834)
27. Moog F, Kotzerke J, Reske SN: FDG PET can replace bone scintigraphy in primary staging of malignant lymphoma. J Nucl Med 40:1407-1413, 1999 (Pubitemid 29428919)